Ibaraki, Japan

Masato Sato

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masato Sato. Retrieved from https://idiyas.com/inventor/masato-sato-zpdaqw69

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Legacy of Masato Sato

Introduction:

Masato Sato, a distinguished inventor hailing from Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals through his groundbreaking work in cephalosporin derivatives.

Latest Patents:

Masato Sato holds a total of 1 patent for his invention of Cephalosporin derivatives. This compound, represented by a specific formula, has demonstrated remarkable antimicrobial activity, showcasing Sato's ingenuity and scientific prowess.

Career Highlights:

Masato Sato is affiliated with the renowned Yamanouchi Pharmaceutical Company Ltd., a prominent player in the pharmaceutical industry. Through his collaboration with this esteemed organization, Sato has been able to bring his innovative ideas to fruition, driving advancements in drug development and healthcare.

Collaborations:

Throughout his career, Masato Sato has had the opportunity to collaborate with esteemed colleagues such as Ryuichiro Hara and Noriaki Nagano. Together, they have worked tirelessly to push the boundaries of pharmaceutical research and pave the way for novel treatments and therapies.

Conclusion:

In conclusion, Masato Sato stands as a testament to the power of innovation and dedication in the realm of pharmaceuticals. His pioneering work in cephalosporin derivatives underscores his commitment to advancing science and improving healthcare outcomes for individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…